Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
A novel blood test analyzing fragments of cell-free DNA showed robust diagnostic performance for colorectal cancer across clinical subgroups, offering a promising noninvasive screening method.
News-Medical.Net on MSN
Highly sensitive CRISPR-based method designed to detect low-frequency cancer mutations
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...
News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
1don MSN
Patients with previously untreatable blood cancer now disease-free after world-first gene therapy
Alyssa Tapley, 16, became the first patient with an aggressive form of leukaemia to have the experimental treatment in 2022.
Scancell reported further positive clinical data for its DNA cancer immunotherapy iSCIB1+, on Tuesday, saying updated phase ...
Groundbreaking research in The Journal of Molecular Diagnostics shows that analysis of specific patterns of cell-free DNA ...
High in the Ecuadorian Andes, at altitudes thousands of meters above sea level, humans face environmental pressures very ...
A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 ...
The immunotherapies used to treat melanoma now include well-established drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) and newer ones such as Amtagvi (lifileucel), which uses T cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback